Swati Kannan is a Dermatology physician affiliated with UC San Diego Health System. OpenAlex indexes 18 publications with 290 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8899 University Center Ln
San Diego, CA 921221013
Telephone
858-657-8322Provider last certified this registry record 4 Nov 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- REVANCE THERAPEUTICS, INC.Program year20241 payment
- PFIZER INC.Program year20231 payment
- Allergan, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
76.9%Tetracycline-class Drug76.9%Doxycycline Hyclate100%Part D≥78 patientsCardiovascular
23.1%Antiarrhythmic23.1%Lidocaine-Prilocaine100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- In Vitro, Ex Vivo and Clinical Trial of Brightening Serum Using a Novel Delivery System on Subjects With Moderate to Severe Dyschromia
Journal of Cosmetic Dermatology
2026 - An Analysis of Recommended Anti-Aging Skin Supplement Videos and Products on TikTok
SKIN The Journal of Cutaneous Medicine
2025 - Perspectives and Practice Patterns of Dermatologists Using Laser Hair Removal for Hidradenitis Suppurativa
Journal of Drugs in Dermatology
2025 - Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis
Journal of Drugs in Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Lowy, MD
UC San Diego Health System
Roger Spragg, MD
UC San Diego Health System
Rafael Bejar, MD, PhD
UC San Diego Health System
Zea Borok, MD
UC San Diego Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”